Literature DB >> 28967582

New HIV diagnoses among adults aged 50 years or older in 31 European countries, 2004-15: an analysis of surveillance data.

Lara Tavoschi1, Joana Gomes Dias2, Anastasia Pharris2.   

Abstract

BACKGROUND: The HIV burden is increasing in older adults in the European Union (EU) and European Economic Area (EEA). We investigated factors associated with HIV diagnosis in older adults in the 31 EU/EEA countries during a 12 year period.
METHODS: In this analysis of surveillance data, we compared data from older people (aged ≥50 years) with those from younger people (aged 15-49 years). We extracted new HIV diagnoses reported to the European Surveillance System between Jan 1, 2004, and Dec 31, 2015, and stratified them by age, sex, migration status, transmission route, and CD4 cell count. We defined late diagnosis as CD4 count of less than 350 cells per μL at diagnosis and diagnosis with advanced HIV disease as less than 200 cells per μL. We compared the two age groups with the χ2 test for difference, and used linear regression analysis to assess temporal trends.
FINDINGS: During the study period 54 102 new HIV diagnoses were reported in older adults. The average notification rate of new diagnoses was 2·6 per 100 000 population across the whole 12 year period, which significantly increased over time (annual average change [AAC] 2·1%, 95% CI 1·1-3·1; p=0·0009). Notification rates for new HIV diagnoses in older adults increased significantly in 16 countries in 2004-15, clustering in central and eastern EU/EEA countries. In 2015, compared with younger adults, older individuals were more likely to originate from the reporting country, to have acquired HIV via heterosexual contact, and to present late (p<0·0001 for all comparisons). HIV diagnoses increased significantly over time among older men (AAC 2·2%, 95% CI 1·2-3·3; p=0·0006), women (1·3%, 0·2-2·4; p=0·025), men who have sex with men (5·8%, 4·3-7·5; p<0·0001), and injecting drug users (7·4%, 4·8-10·2; p<0·0001).
INTERPRETATION: Our findings suggest that there is a compelling need to deliver more targeted testing interventions for older adults and the general adult population, such as by increasing awareness among health-care workers and expanding opportunities for provider-initiated and indicator-condition-guided testing programmes. FUNDING: European Centre for Disease Prevention and Control.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28967582     DOI: 10.1016/S2352-3018(17)30155-8

Source DB:  PubMed          Journal:  Lancet HIV        ISSN: 2352-3018            Impact factor:   12.767


  27 in total

Review 1.  Pre-exposure Prophylaxis for HIV Infection in the Older Patient: What can be Recommended?

Authors:  Iacopo Franconi; Giovanni Guaraldi
Journal:  Drugs Aging       Date:  2018-06       Impact factor: 3.923

2.  Exogenous steroid-induced hypoadrenalism in a person living with HIV caused by a drug-drug interaction between cobicistat and intrabursal triamcinolone.

Authors:  Navnit Makaram; Clark D Russell; Simon Benedict Roberts; Jarrad Stevens; Gavin Macpherson
Journal:  BMJ Case Rep       Date:  2018-12-14

Review 3.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

4.  HIV diagnosed after 50 years of age.

Authors:  Jacqueline M McMillan; Leah H Rubin; M John Gill
Journal:  CMAJ       Date:  2020-03-09       Impact factor: 8.262

5.  The Global Impact of HIV on Sexual and Gender Minority Older Adults: Challenges, Progress, and Future Directions.

Authors:  Charles A Emlet; Kelly K O'Brien; Karen Fredriksen Goldsen
Journal:  Int J Aging Hum Dev       Date:  2019-04-22

Review 6.  Delayed presentation of HIV among older individuals: a growing problem.

Authors:  Amy C Justice; Matthew B Goetz; Cameron N Stewart; Brenna C Hogan; Elizabeth Humes; Paula M Luz; Jessica L Castilho; Denis Nash; Ellen Brazier; Beverly Musick; Constantin Yiannoutsos; Karen Malateste; Antoine Jaquet; Morna Cornell; Tinei Shamu; Reena Rajasuriar; Awachana Jiamsakul; Keri N Althoff
Journal:  Lancet HIV       Date:  2022-02-23       Impact factor: 16.070

7.  Age-related factors influence HIV testing within subpopulations: a cross-sectional survey of MSM within the Celtic nations.

Authors:  Jenny Dalrymple; Kareena McAloney-Kocaman; Paul Flowers; Lisa M McDaid; Jamie Scott Frankis
Journal:  Sex Transm Infect       Date:  2019-06-14       Impact factor: 3.519

8.  Preferences for HIV testing services among men who have sex with men in the UK: A discrete choice experiment.

Authors:  Alec Miners; Tom Nadarzynski; Charles Witzel; Andrew N Phillips; Valentina Cambiano; Alison J Rodger; Carrie D Llewellyn
Journal:  PLoS Med       Date:  2019-04-11       Impact factor: 11.069

9.  Newly diagnosed cases of HIV in those aged 50 years and older and those less than 50: 2008-2017.

Authors:  N Haddad; A Robert; N Popovic; O Varsaneux; M Edmunds; L Jonah; W Siu; A Weeks; C Archibald
Journal:  Can Commun Dis Rep       Date:  2019-11-07

10.  Effects of age, HIV, and HIV-associated clinical factors on neuropsychological functioning and brain regional volume in HIV+ patients on effective treatment.

Authors:  Natalia Gawron; M Choiński; B Szymańska-Kotwica; A Pluta; M Sobańska; A R Egbert; A Desowska; T Wolak; A Horban; E Firląg-Burkacka; P Bieńkowski; H Sienkiewicz-Jarosz; A Scińska-Bieńkowska; B Biswal; S M Rao; R Bornstein; E Łojek
Journal:  J Neurovirol       Date:  2018-10-08       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.